Although the unmet need is high, and traditional treatment options for preventing hyperammonemia are limited, preclinical results for CPS1 gene therapy suggest some promise (Nitzahn et al., 2020; Diep et al., 2024). Here, CPS1 is linked to Hyperammonemia.